Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up

Higa, Kelvin; Ho, Tienchin; Tercero, Francisco; Yunus, Tahir E.; Boone, Keith

doi:10.1016/j.soard.2010.10.019

Cited by 369 publications

(188 citation statements)

References 27 publications

Supporting

Mentioning

147

Contrasting

Unclassified

Order By: Relevance

“…Most bariatric centers refer patients with clinical symptoms of OSA for PSG but do not routinely refer all patients for preoperative testing, given the inconclusiveness of evidence supporting the benefi ts of preoperative treatment, and the knowledge that OSA often improves or resolves postoperatively. [18][19][20][21][22] As an example, in a study of 1,095 patients who underwent laparoscopic Roux-en-Y gastric bypass at an academic medical center in the US, screening for OSA was not useful in predicting postoperative pulmonary complications, provided all patients were observed in a monitored BRIEF SUMMARY Current knowledge/Study Rationale: The prevalence of obstructive sleep apnea and the role of screening questionnaires in patients presenting for bariatric surgery is not clear. Study Impact: This study shows that 80% of subjects who had polysomnography within 12 months from bariatric surgery had sleep apnea.…”

Section: S C I E N T I F I C I N V E S T I G a T I O N Smentioning

confidence: 99%

Assessment of Obstructive Sleep Apnea in Adults Undergoing Bariatric Surgery in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) Study

Khan

King

Patterson

et al. 2013

Journal of Clinical Sleep Medicine

View full text Add to dashboard Cite

Section: S C I E N T I F I C I N V E S T I G a T I O N Smentioning

confidence: 99%

Assessment of Obstructive Sleep Apnea in Adults Undergoing Bariatric Surgery in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) Study

Khan

King

Patterson

et al. 2013

Journal of Clinical Sleep Medicine

View full text Add to dashboard Cite

“…Obeid et al, discussed their tremendous resolution rate of T2DM. They acknowledged that only a select number of studies have reported T2DM resolution rates similar to theirs [17,19,22]. However, Obeid et al, argue that there is evidence in the literature for a relationship between the maintenance of weight loss and remission of comorbidites, such as T2DM [23].…”

Section: Rygb and Long-term T2dm Resolutionmentioning

confidence: 98%

“…A recent retrospective review by Higa et al, also reported long-term outcomes for RYGB surgery [22]. Their study included 242 patients with the majority of patients having a BMI between 40-50 kg/m 2 .…”

Section: Rygb and Long-term T2dm Resolutionmentioning

confidence: 99%

Treatment of obesity and diabetes with bariatric surgery

Whitlock¹,

Gill²,

Switzers³

et al. 2013

Glob Epidemi Obes

View full text Add to dashboard Cite

Obesity rates are on the rise worldwide. Nearly 1 in every 4 Canadians is classified as being overweight. With an increase in obesity, there is also a correlated rise in its comorbidities, most notably Type-2 Diabetes Mellitus (T2DM). Bariatric surgery is superior to diet and lifestyle management in managing the severe obese. These bariatric procedures are traditionally classified as either being restrictive(reducing caloric intake), or malabsorptive (re-routing the gastrointestinal tract). The roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery. Studies have shown that post-RYGB, there is a significant improvement or even complete resolution in patients' type-2 diabetes mellitus (T2DM), with significantly more patients achieving euglycemia compared to the control population. RYGB has also been shown to prevent the development of T2DM. When RYGB was compared to more restrictive procedures, it achieved superior results in both weight-loss and T2DM resolution and the maintenance of these results long-term. The superiority of procedures, such as RYGB, is potentially explained through alterations in gut hormones, ghrelin and GLP-1. In this review, we explore the role of bariatric surgery in the prevention and treatment of T2DM, with a specific focus on the recent evidence surrounding surgical treatment via RYGB.

show abstract

“…Following the introduction of the laparoscopic era, laparoscopic R‐Y gastric bypass (LRYGB) has accelerated the development of both bariatric and metabolic surgery 44. Long‐term (>10 years) weight loss after RYGB was reported to be around 25‐30% total weight loss and 55‐70% excess weight loss ( EWL) 33, 34, 35, 36, 37, 38. Up to 20% of RYGB patients may require revision surgery for various complications or weight regain.…”

Section: New Procedures With Better Outcomesmentioning

confidence: 99%

Recent advancements in bariatric/metabolic surgery

Lee

Almalki

2017

Annals of Gastroent Surgery

View full text Add to dashboard Cite

Obesity and type 2 diabetes mellitus (T2DM) are currently two pan‐endemic health problems worldwide and are associated with considerable increase in morbidity and mortality. Both diseases are closely related and very difficult to control by current medical treatment, including diet, drug therapy and behavioral modification. Bariatric surgery has proven successful in treating not just obesity but also in significantly decreasing overall obesity‐associated morbidities as well as improving quality of life in severely obese patients (body mass index [BMI] >35 kg/m2). A rapid increase in bariatric surgery started in the 2000s when the laparoscopic surgical technique was introduced into this field. Many new procedures had been developed and changed the face of modern bariatric surgery. Recently, bariatric surgery played as gastrointestinal metabolic surgery has been proposed as a new treatment modality for obesity‐related T2DM for patients with BMI >35 kg/m2. Strong evidence has demonstrated that bariatric/metabolic surgery is an effective and durable treatment for obese T2DM patients. Bariatric/metabolic surgery is now becoming an important surgical division. The present article examines and discusses recent advancements in bariatric/metabolic surgery and covers four major fields: (i) the rapid increase in numbers and better safety; (ii) new procedures with better outcomes; (iii) from bariatric to metabolic surgery; and (iv) understanding the mechanisms and personalized treatment.

show abstract

Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up

Cited by 369 publications

References 27 publications

Assessment of Obstructive Sleep Apnea in Adults Undergoing Bariatric Surgery in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) Study

Assessment of Obstructive Sleep Apnea in Adults Undergoing Bariatric Surgery in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) Study

Treatment of obesity and diabetes with bariatric surgery

Recent advancements in bariatric/metabolic surgery

Contact Info

Product

Resources

About